nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—GSR—Glutathione metabolism—GSTA1—liver cancer	0.024	0.051	CbGpPWpGaD
Carmustine—GSR—Glutathione metabolism—GPX3—liver cancer	0.0202	0.0429	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—GPX3—liver cancer	0.0177	0.0377	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—NFE2L2—liver cancer	0.0171	0.0363	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—GPX3—liver cancer	0.0163	0.0347	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—EPT1—liver cancer	0.0156	0.0332	CbGpPWpGaD
Carmustine—GSR—Glutathione metabolism—GGT1—liver cancer	0.0142	0.0302	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—CYCS—liver cancer	0.0127	0.0271	CbGpPWpGaD
Carmustine—GSR—Glutathione metabolism—GSTM1—liver cancer	0.0117	0.0249	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—GSTP1—liver cancer	0.0112	0.0238	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—DNAJB1—liver cancer	0.0111	0.0235	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—HMOX1—liver cancer	0.0102	0.0216	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—CYP1A1—liver cancer	0.00898	0.0191	CbGpPWpGaD
Carmustine—CYP1A2—Arylamine metabolism—NAT2—liver cancer	0.00856	0.0182	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—MAPK14—liver cancer	0.00759	0.0161	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—GPX3—liver cancer	0.0069	0.0147	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—DNAJB1—liver cancer	0.0069	0.0147	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GSTA3—liver cancer	0.00636	0.0135	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GSTA4—liver cancer	0.00582	0.0124	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GSTA2—liver cancer	0.00567	0.0121	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—GSTA3—liver cancer	0.0055	0.0117	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GSTA1—liver cancer	0.00547	0.0116	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—GSTA4—liver cancer	0.00503	0.0107	CbGpPWpGaD
Carmustine—Skin exfoliation—Sorafenib—liver cancer	0.00503	0.0095	CcSEcCtD
Carmustine—Neuropathy—Sorafenib—liver cancer	0.00495	0.00935	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—GGT1—liver cancer	0.00485	0.0103	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—NFE2L2—liver cancer	0.00482	0.0102	CbGpPWpGaD
Carmustine—Neoplasm—Sorafenib—liver cancer	0.00477	0.009	CcSEcCtD
Carmustine—Gynaecomastia—Sorafenib—liver cancer	0.00472	0.00891	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—NAT2—liver cancer	0.00468	0.00995	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—TGFA—liver cancer	0.0046	0.00978	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GPX3—liver cancer	0.0046	0.00978	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SERPINA1—liver cancer	0.00453	0.00964	CbGpPWpGaD
Carmustine—Myelosuppression—Epirubicin—liver cancer	0.00415	0.00785	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—GPX3—liver cancer	0.00398	0.00846	CbGpPWpGaD
Carmustine—Myelosuppression—Doxorubicin—liver cancer	0.00384	0.00726	CcSEcCtD
Carmustine—Hyponatraemia—Sorafenib—liver cancer	0.00384	0.00726	CcSEcCtD
Carmustine—CYP1A2—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00374	0.00794	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen metabolism—GSTA1—liver cancer	0.00359	0.00764	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—MTHFR—liver cancer	0.00354	0.00752	CbGpPWpGaD
Carmustine—Hypokalaemia—Sorafenib—liver cancer	0.00348	0.00658	CcSEcCtD
Carmustine—Dysphagia—Sorafenib—liver cancer	0.00331	0.00625	CcSEcCtD
Carmustine—Skin hyperpigmentation—Epirubicin—liver cancer	0.00327	0.00619	CcSEcCtD
Carmustine—Febrile neutropenia—Epirubicin—liver cancer	0.00324	0.00612	CcSEcCtD
Carmustine—GSR—NRF2 pathway—GGT1—liver cancer	0.00324	0.00688	CbGpPWpGaD
Carmustine—Transaminases increased—Epirubicin—liver cancer	0.0032	0.00605	CcSEcCtD
Carmustine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—liver cancer	0.00318	0.00676	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—F2—liver cancer	0.00311	0.00661	CbGpPWpGaD
Carmustine—Myasthenia—Epirubicin—liver cancer	0.0031	0.00585	CcSEcCtD
Carmustine—Neutropenia—Sorafenib—liver cancer	0.00309	0.00584	CcSEcCtD
Carmustine—Oral candidiasis—Epirubicin—liver cancer	0.00307	0.00579	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—CYP2E1—liver cancer	0.00305	0.00648	CbGpPWpGaD
Carmustine—Skin hyperpigmentation—Doxorubicin—liver cancer	0.00303	0.00572	CcSEcCtD
Carmustine—Febrile neutropenia—Doxorubicin—liver cancer	0.003	0.00566	CcSEcCtD
Carmustine—Pneumonia—Sorafenib—liver cancer	0.00297	0.0056	CcSEcCtD
Carmustine—Transaminases increased—Doxorubicin—liver cancer	0.00296	0.0056	CcSEcCtD
Carmustine—Cyst—Epirubicin—liver cancer	0.00291	0.0055	CcSEcCtD
Carmustine—GSR—NRF2 pathway—GSTP1—liver cancer	0.00291	0.00618	CbGpPWpGaD
Carmustine—Renal failure—Sorafenib—liver cancer	0.0029	0.00547	CcSEcCtD
Carmustine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—liver cancer	0.0029	0.00616	CbGpPWpGaD
Carmustine—Neuropathy peripheral—Sorafenib—liver cancer	0.00289	0.00546	CcSEcCtD
Carmustine—Hypokinesia—Epirubicin—liver cancer	0.00289	0.00545	CcSEcCtD
Carmustine—Stomatitis—Sorafenib—liver cancer	0.00287	0.00543	CcSEcCtD
Carmustine—GSR—NRF2 pathway—HMOX1—liver cancer	0.00287	0.00609	CbGpPWpGaD
Carmustine—Myasthenia—Doxorubicin—liver cancer	0.00287	0.00542	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—GPX3—liver cancer	0.00286	0.00609	CbGpPWpGaD
Carmustine—Oral candidiasis—Doxorubicin—liver cancer	0.00284	0.00536	CcSEcCtD
Carmustine—Burning sensation—Epirubicin—liver cancer	0.0028	0.0053	CcSEcCtD
Carmustine—Thrombosis—Epirubicin—liver cancer	0.00275	0.0052	CcSEcCtD
Carmustine—Cyst—Doxorubicin—liver cancer	0.0027	0.00509	CcSEcCtD
Carmustine—GSR—NRF2 pathway—HGF—liver cancer	0.00267	0.00568	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GSTM1—liver cancer	0.00267	0.00568	CbGpPWpGaD
Carmustine—Hypokinesia—Doxorubicin—liver cancer	0.00267	0.00504	CcSEcCtD
Carmustine—Haemoglobin—Sorafenib—liver cancer	0.00266	0.00502	CcSEcCtD
Carmustine—Haemorrhage—Sorafenib—liver cancer	0.00265	0.005	CcSEcCtD
Carmustine—Connective tissue disorder—Sorafenib—liver cancer	0.0026	0.00491	CcSEcCtD
Carmustine—Burning sensation—Doxorubicin—liver cancer	0.00259	0.0049	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—SERPINE1—liver cancer	0.00259	0.0055	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—ALB—liver cancer	0.00258	0.00549	CbGpPWpGaD
Carmustine—Scotoma—Epirubicin—liver cancer	0.00256	0.00484	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00256	0.00543	CbGpPWpGaD
Carmustine—Thrombosis—Doxorubicin—liver cancer	0.00255	0.00481	CcSEcCtD
Carmustine—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00254	0.00541	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—GSTP1—liver cancer	0.00252	0.00535	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00251	0.00534	CbGpPWpGaD
Carmustine—Necrosis—Epirubicin—liver cancer	0.00248	0.00469	CcSEcCtD
Carmustine—Abscess—Epirubicin—liver cancer	0.00246	0.00465	CcSEcCtD
Carmustine—Flushing—Sorafenib—liver cancer	0.00246	0.00464	CcSEcCtD
Carmustine—Injection site pain—Epirubicin—liver cancer	0.00239	0.00451	CcSEcCtD
Carmustine—Scotoma—Doxorubicin—liver cancer	0.00237	0.00448	CcSEcCtD
Carmustine—Arrhythmia—Sorafenib—liver cancer	0.00236	0.00447	CcSEcCtD
Carmustine—Alopecia—Sorafenib—liver cancer	0.00234	0.00442	CcSEcCtD
Carmustine—Mental disorder—Sorafenib—liver cancer	0.00232	0.00438	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—GSTM1—liver cancer	0.00231	0.00491	CbGpPWpGaD
Carmustine—Malnutrition—Sorafenib—liver cancer	0.0023	0.00435	CcSEcCtD
Carmustine—Erythema—Sorafenib—liver cancer	0.0023	0.00435	CcSEcCtD
Carmustine—Necrosis—Doxorubicin—liver cancer	0.0023	0.00434	CcSEcCtD
Carmustine—Abscess—Doxorubicin—liver cancer	0.00228	0.0043	CcSEcCtD
Carmustine—Extravasation—Epirubicin—liver cancer	0.00223	0.00422	CcSEcCtD
Carmustine—Injection site pain—Doxorubicin—liver cancer	0.00221	0.00417	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—CYP1A1—liver cancer	0.00219	0.00466	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—liver cancer	0.00216	0.00459	CbGpPWpGaD
Carmustine—Anaemia—Sorafenib—liver cancer	0.00213	0.00402	CcSEcCtD
Carmustine—CYP1A2—Xenobiotics—CYP2E1—liver cancer	0.00213	0.00452	CbGpPWpGaD
Carmustine—Thinking abnormal—Epirubicin—liver cancer	0.00213	0.00402	CcSEcCtD
Carmustine—Extravasation—Doxorubicin—liver cancer	0.00207	0.0039	CcSEcCtD
Carmustine—Leukopenia—Sorafenib—liver cancer	0.00206	0.0039	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CYCS—liver cancer	0.00205	0.00436	CbGpPWpGaD
Carmustine—CYP1A2—Tamoxifen metabolism—CYP2E1—liver cancer	0.00205	0.00435	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—UGDH—liver cancer	0.00204	0.00434	CbGpPWpGaD
Carmustine—CYP1A2—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00204	0.00433	CbGpPWpGaD
Carmustine—Gait disturbance—Epirubicin—liver cancer	0.002	0.00377	CcSEcCtD
Carmustine—Hypertension—Sorafenib—liver cancer	0.00199	0.00376	CcSEcCtD
Carmustine—Coordination abnormal—Epirubicin—liver cancer	0.00198	0.00375	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—PPARA—liver cancer	0.00197	0.0042	CbGpPWpGaD
Carmustine—Neck pain—Epirubicin—liver cancer	0.00197	0.00372	CcSEcCtD
Carmustine—Thinking abnormal—Doxorubicin—liver cancer	0.00197	0.00372	CcSEcCtD
Carmustine—Myalgia—Sorafenib—liver cancer	0.00196	0.0037	CcSEcCtD
Carmustine—Pulmonary embolism—Epirubicin—liver cancer	0.00195	0.00368	CcSEcCtD
Carmustine—Injection site reaction—Epirubicin—liver cancer	0.00194	0.00366	CcSEcCtD
Carmustine—Infection—Sorafenib—liver cancer	0.00187	0.00353	CcSEcCtD
Carmustine—Candida infection—Epirubicin—liver cancer	0.00186	0.00351	CcSEcCtD
Carmustine—Skin exfoliation—Epirubicin—liver cancer	0.00186	0.00351	CcSEcCtD
Carmustine—Gait disturbance—Doxorubicin—liver cancer	0.00185	0.00349	CcSEcCtD
Carmustine—Thrombocytopenia—Sorafenib—liver cancer	0.00184	0.00348	CcSEcCtD
Carmustine—Coordination abnormal—Doxorubicin—liver cancer	0.00184	0.00347	CcSEcCtD
Carmustine—Neuropathy—Epirubicin—liver cancer	0.00183	0.00345	CcSEcCtD
Carmustine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00183	0.00389	CbGpPWpGaD
Carmustine—Neck pain—Doxorubicin—liver cancer	0.00182	0.00345	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—GSTP1—liver cancer	0.00181	0.00385	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—liver cancer	0.0018	0.00383	CbGpPWpGaD
Carmustine—Pulmonary embolism—Doxorubicin—liver cancer	0.0018	0.0034	CcSEcCtD
Carmustine—Anorexia—Sorafenib—liver cancer	0.00179	0.00339	CcSEcCtD
Carmustine—Injection site reaction—Doxorubicin—liver cancer	0.00179	0.00338	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—ESR1—liver cancer	0.00179	0.0038	CbGpPWpGaD
Carmustine—Coma—Epirubicin—liver cancer	0.00178	0.00336	CcSEcCtD
Carmustine—Neoplasm—Epirubicin—liver cancer	0.00176	0.00333	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—GSTA2—liver cancer	0.00176	0.00374	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen metabolism—GSTM1—liver cancer	0.00176	0.00373	CbGpPWpGaD
Carmustine—Candida infection—Doxorubicin—liver cancer	0.00172	0.00325	CcSEcCtD
Carmustine—Skin exfoliation—Doxorubicin—liver cancer	0.00172	0.00325	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00171	0.00324	CcSEcCtD
Carmustine—Abnormal vision—Epirubicin—liver cancer	0.0017	0.00321	CcSEcCtD
Carmustine—Neuropathy—Doxorubicin—liver cancer	0.00169	0.0032	CcSEcCtD
Carmustine—Sepsis—Epirubicin—liver cancer	0.00169	0.00319	CcSEcCtD
Carmustine—Mental disability—Epirubicin—liver cancer	0.00169	0.00319	CcSEcCtD
Carmustine—Dyspnoea—Sorafenib—liver cancer	0.00168	0.00317	CcSEcCtD
Carmustine—CYP1A2—Estrogen metabolism—CYP1A1—liver cancer	0.00166	0.00354	CbGpPWpGaD
Carmustine—GSR—Metabolism—UGDH—liver cancer	0.00166	0.00353	CbGpPWpGaD
Carmustine—Coma—Doxorubicin—liver cancer	0.00165	0.00311	CcSEcCtD
Carmustine—Phlebitis—Epirubicin—liver cancer	0.00164	0.0031	CcSEcCtD
Carmustine—Decreased appetite—Sorafenib—liver cancer	0.00163	0.00309	CcSEcCtD
Carmustine—Thrombophlebitis—Epirubicin—liver cancer	0.00163	0.00308	CcSEcCtD
Carmustine—Neoplasm—Doxorubicin—liver cancer	0.00163	0.00308	CcSEcCtD
Carmustine—Diabetes mellitus—Epirubicin—liver cancer	0.00163	0.00307	CcSEcCtD
Carmustine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00162	0.00307	CcSEcCtD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00162	0.00345	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—H2AFX—liver cancer	0.00162	0.00345	CbGpPWpGaD
Carmustine—Constipation—Sorafenib—liver cancer	0.00161	0.00304	CcSEcCtD
Carmustine—Pain—Sorafenib—liver cancer	0.00161	0.00304	CcSEcCtD
Carmustine—Abnormal vision—Doxorubicin—liver cancer	0.00157	0.00297	CcSEcCtD
Carmustine—Eye pain—Epirubicin—liver cancer	0.00157	0.00296	CcSEcCtD
Carmustine—Mental disability—Doxorubicin—liver cancer	0.00156	0.00295	CcSEcCtD
Carmustine—Sepsis—Doxorubicin—liver cancer	0.00156	0.00295	CcSEcCtD
Carmustine—GSR—Metabolism—EPT1—liver cancer	0.00156	0.00332	CbGpPWpGaD
Carmustine—Gastrointestinal pain—Sorafenib—liver cancer	0.00154	0.0029	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—liver cancer	0.00153	0.00326	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—AHR—liver cancer	0.00153	0.00326	CbGpPWpGaD
Carmustine—CYP1A2—Xenobiotics—CYP1A1—liver cancer	0.00153	0.00325	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—TNF—liver cancer	0.00152	0.00324	CbGpPWpGaD
Carmustine—Phlebitis—Doxorubicin—liver cancer	0.00152	0.00287	CcSEcCtD
Carmustine—Thrombophlebitis—Doxorubicin—liver cancer	0.00151	0.00285	CcSEcCtD
Carmustine—Diabetes mellitus—Doxorubicin—liver cancer	0.0015	0.00284	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—liver cancer	0.0015	0.00318	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—liver cancer	0.0015	0.00318	CbGpPWpGaD
Carmustine—Abdominal pain—Sorafenib—liver cancer	0.00149	0.00281	CcSEcCtD
Carmustine—Body temperature increased—Sorafenib—liver cancer	0.00149	0.00281	CcSEcCtD
Carmustine—GSR—Metabolism—TAT—liver cancer	0.00148	0.00315	CbGpPWpGaD
Carmustine—CYP1A2—Tamoxifen metabolism—CYP1A1—liver cancer	0.00147	0.00313	CbGpPWpGaD
Carmustine—Eye pain—Doxorubicin—liver cancer	0.00145	0.00274	CcSEcCtD
Carmustine—Hyponatraemia—Epirubicin—liver cancer	0.00142	0.00268	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00141	0.00267	CcSEcCtD
Carmustine—Diplopia—Epirubicin—liver cancer	0.00141	0.00267	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00139	0.00296	CbGpPWpGaD
Carmustine—Hypersensitivity—Sorafenib—liver cancer	0.00139	0.00262	CcSEcCtD
Carmustine—Face oedema—Epirubicin—liver cancer	0.00137	0.00258	CcSEcCtD
Carmustine—Asthenia—Sorafenib—liver cancer	0.00135	0.00255	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—liver cancer	0.00134	0.00285	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAPK14—liver cancer	0.00133	0.00283	CbGpPWpGaD
Carmustine—Ataxia—Epirubicin—liver cancer	0.00133	0.00251	CcSEcCtD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00132	0.0028	CbGpPWpGaD
Carmustine—Hyponatraemia—Doxorubicin—liver cancer	0.00131	0.00248	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00131	0.00247	CcSEcCtD
Carmustine—Diplopia—Doxorubicin—liver cancer	0.00131	0.00247	CcSEcCtD
Carmustine—Liver function test abnormal—Epirubicin—liver cancer	0.00131	0.00247	CcSEcCtD
Carmustine—Hypokalaemia—Epirubicin—liver cancer	0.00129	0.00243	CcSEcCtD
Carmustine—Diarrhoea—Sorafenib—liver cancer	0.00129	0.00243	CcSEcCtD
Carmustine—Face oedema—Doxorubicin—liver cancer	0.00126	0.00239	CcSEcCtD
Carmustine—CYP1A2—Arachidonic acid metabolism—HPGDS—liver cancer	0.00125	0.00267	CbGpPWpGaD
Carmustine—Muscular weakness—Epirubicin—liver cancer	0.00125	0.00236	CcSEcCtD
Carmustine—Dizziness—Sorafenib—liver cancer	0.00124	0.00235	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—IL6—liver cancer	0.00123	0.00262	CbGpPWpGaD
Carmustine—Ataxia—Doxorubicin—liver cancer	0.00123	0.00232	CcSEcCtD
Carmustine—Dysphagia—Epirubicin—liver cancer	0.00122	0.00231	CcSEcCtD
Carmustine—Liver function test abnormal—Doxorubicin—liver cancer	0.00121	0.00228	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—UGDH—liver cancer	0.0012	0.00254	CbGpPWpGaD
Carmustine—Vomiting—Sorafenib—liver cancer	0.0012	0.00226	CcSEcCtD
Carmustine—Hypokalaemia—Doxorubicin—liver cancer	0.00119	0.00225	CcSEcCtD
Carmustine—Rash—Sorafenib—liver cancer	0.00119	0.00224	CcSEcCtD
Carmustine—Dermatitis—Sorafenib—liver cancer	0.00118	0.00224	CcSEcCtD
Carmustine—Headache—Sorafenib—liver cancer	0.00118	0.00222	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GSTA3—liver cancer	0.00117	0.0025	CbGpPWpGaD
Carmustine—Pancytopenia—Epirubicin—liver cancer	0.00116	0.00219	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—JUN—liver cancer	0.00116	0.00246	CbGpPWpGaD
Carmustine—Muscular weakness—Doxorubicin—liver cancer	0.00115	0.00218	CcSEcCtD
Carmustine—Neutropenia—Epirubicin—liver cancer	0.00114	0.00216	CcSEcCtD
Carmustine—CYP1A2—Melatonin metabolism and effects—CYP1A1—liver cancer	0.00114	0.00241	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—liver cancer	0.00113	0.00241	CbGpPWpGaD
Carmustine—Dysphagia—Doxorubicin—liver cancer	0.00113	0.00214	CcSEcCtD
Carmustine—Nausea—Sorafenib—liver cancer	0.00112	0.00211	CcSEcCtD
Carmustine—Hyperglycaemia—Epirubicin—liver cancer	0.0011	0.00208	CcSEcCtD
Carmustine—Pneumonia—Epirubicin—liver cancer	0.0011	0.00207	CcSEcCtD
Carmustine—CYP1A2—Tryptophan metabolism—CYP2E1—liver cancer	0.00109	0.00232	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—TGFB1—liver cancer	0.00109	0.00231	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTA4—liver cancer	0.00107	0.00228	CbGpPWpGaD
Carmustine—Pancytopenia—Doxorubicin—liver cancer	0.00107	0.00203	CcSEcCtD
Carmustine—Renal failure—Epirubicin—liver cancer	0.00107	0.00202	CcSEcCtD
Carmustine—Neuropathy peripheral—Epirubicin—liver cancer	0.00107	0.00202	CcSEcCtD
Carmustine—Stomatitis—Epirubicin—liver cancer	0.00106	0.00201	CcSEcCtD
Carmustine—Urinary tract infection—Epirubicin—liver cancer	0.00106	0.002	CcSEcCtD
Carmustine—Neutropenia—Doxorubicin—liver cancer	0.00106	0.002	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GSTA2—liver cancer	0.00105	0.00222	CbGpPWpGaD
Carmustine—Hyperglycaemia—Doxorubicin—liver cancer	0.00102	0.00193	CcSEcCtD
Carmustine—Pneumonia—Doxorubicin—liver cancer	0.00101	0.00192	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GSTA1—liver cancer	0.00101	0.00215	CbGpPWpGaD
Carmustine—GSR—Metabolism—CPT1B—liver cancer	0.00101	0.00214	CbGpPWpGaD
Carmustine—GSR—Metabolism—GLUL—liver cancer	0.00101	0.00214	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN2A—liver cancer	0.001	0.00213	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—STAT3—liver cancer	0.001	0.00213	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—NAT2—liver cancer	0.000998	0.00212	CbGpPWpGaD
Carmustine—Renal failure—Doxorubicin—liver cancer	0.000991	0.00187	CcSEcCtD
Carmustine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000988	0.00187	CcSEcCtD
Carmustine—Haemoglobin—Epirubicin—liver cancer	0.000983	0.00186	CcSEcCtD
Carmustine—Stomatitis—Doxorubicin—liver cancer	0.000983	0.00186	CcSEcCtD
Carmustine—Urinary tract infection—Doxorubicin—liver cancer	0.00098	0.00185	CcSEcCtD
Carmustine—Haemorrhage—Epirubicin—liver cancer	0.000978	0.00185	CcSEcCtD
Carmustine—Hypoaesthesia—Epirubicin—liver cancer	0.000973	0.00184	CcSEcCtD
Carmustine—GSR—Metabolism—NR1H4—liver cancer	0.000971	0.00206	CbGpPWpGaD
Carmustine—Oedema peripheral—Epirubicin—liver cancer	0.000964	0.00182	CcSEcCtD
Carmustine—Connective tissue disorder—Epirubicin—liver cancer	0.000961	0.00182	CcSEcCtD
Carmustine—GSR—Metabolism—GSTA3—liver cancer	0.000954	0.00203	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MTOR—liver cancer	0.000947	0.00201	CbGpPWpGaD
Carmustine—Visual impairment—Epirubicin—liver cancer	0.000943	0.00178	CcSEcCtD
Carmustine—CYP1A2—Arachidonic acid metabolism—GGT1—liver cancer	0.000939	0.002	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000915	0.00194	CbGpPWpGaD
Carmustine—Eye disorder—Epirubicin—liver cancer	0.000914	0.00173	CcSEcCtD
Carmustine—Haemoglobin—Doxorubicin—liver cancer	0.00091	0.00172	CcSEcCtD
Carmustine—Flushing—Epirubicin—liver cancer	0.000908	0.00171	CcSEcCtD
Carmustine—Haemorrhage—Doxorubicin—liver cancer	0.000905	0.00171	CcSEcCtD
Carmustine—Hypoaesthesia—Doxorubicin—liver cancer	0.000901	0.0017	CcSEcCtD
Carmustine—Oedema peripheral—Doxorubicin—liver cancer	0.000892	0.00168	CcSEcCtD
Carmustine—Connective tissue disorder—Doxorubicin—liver cancer	0.000889	0.00168	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CDKN1B—liver cancer	0.000888	0.00189	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000884	0.00188	CbGpPWpGaD
Carmustine—Arrhythmia—Epirubicin—liver cancer	0.000874	0.00165	CcSEcCtD
Carmustine—GSR—Metabolism—GSTA4—liver cancer	0.000873	0.00186	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000872	0.00185	CbGpPWpGaD
Carmustine—Visual impairment—Doxorubicin—liver cancer	0.000872	0.00165	CcSEcCtD
Carmustine—Alopecia—Epirubicin—liver cancer	0.000864	0.00163	CcSEcCtD
Carmustine—Mental disorder—Epirubicin—liver cancer	0.000857	0.00162	CcSEcCtD
Carmustine—Malnutrition—Epirubicin—liver cancer	0.000852	0.00161	CcSEcCtD
Carmustine—Erythema—Epirubicin—liver cancer	0.000852	0.00161	CcSEcCtD
Carmustine—GSR—Metabolism—GSTA2—liver cancer	0.000851	0.00181	CbGpPWpGaD
Carmustine—Eye disorder—Doxorubicin—liver cancer	0.000846	0.0016	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—JUN—liver cancer	0.000846	0.0018	CbGpPWpGaD
Carmustine—Flushing—Doxorubicin—liver cancer	0.00084	0.00159	CcSEcCtD
Carmustine—Back pain—Epirubicin—liver cancer	0.000824	0.00156	CcSEcCtD
Carmustine—GSR—Metabolism—GSTA1—liver cancer	0.000821	0.00174	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN1A—liver cancer	0.00082	0.00174	CbGpPWpGaD
Carmustine—GSR—Metabolism—NAT2—liver cancer	0.000812	0.00172	CbGpPWpGaD
Carmustine—Arrhythmia—Doxorubicin—liver cancer	0.000809	0.00153	CcSEcCtD
Carmustine—Vision blurred—Epirubicin—liver cancer	0.000802	0.00152	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—MAPK8—liver cancer	0.0008	0.0017	CbGpPWpGaD
Carmustine—Alopecia—Doxorubicin—liver cancer	0.0008	0.00151	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—HPGDS—liver cancer	0.000798	0.0017	CbGpPWpGaD
Carmustine—Mental disorder—Doxorubicin—liver cancer	0.000793	0.0015	CcSEcCtD
Carmustine—Malnutrition—Doxorubicin—liver cancer	0.000788	0.00149	CcSEcCtD
Carmustine—Erythema—Doxorubicin—liver cancer	0.000788	0.00149	CcSEcCtD
Carmustine—Anaemia—Epirubicin—liver cancer	0.000787	0.00149	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—liver cancer	0.000785	0.00167	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—CYP1A1—liver cancer	0.000785	0.00167	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.000785	0.00167	CbGpPWpGaD
Carmustine—Agitation—Epirubicin—liver cancer	0.000783	0.00148	CcSEcCtD
Carmustine—GSR—Metabolism—ALDOB—liver cancer	0.000778	0.00165	CbGpPWpGaD
Carmustine—Leukopenia—Epirubicin—liver cancer	0.000762	0.00144	CcSEcCtD
Carmustine—Back pain—Doxorubicin—liver cancer	0.000762	0.00144	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000756	0.00161	CbGpPWpGaD
Carmustine—Vision blurred—Doxorubicin—liver cancer	0.000743	0.0014	CcSEcCtD
Carmustine—GSR—Metabolism—CRABP1—liver cancer	0.000742	0.00158	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—VEGFA—liver cancer	0.000739	0.00157	CbGpPWpGaD
Carmustine—Convulsion—Epirubicin—liver cancer	0.000738	0.00139	CcSEcCtD
Carmustine—Hypertension—Epirubicin—liver cancer	0.000735	0.00139	CcSEcCtD
Carmustine—CYP1A2—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000735	0.00156	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—STAT3—liver cancer	0.000732	0.00155	CbGpPWpGaD
Carmustine—Anaemia—Doxorubicin—liver cancer	0.000728	0.00138	CcSEcCtD
Carmustine—Chest pain—Epirubicin—liver cancer	0.000725	0.00137	CcSEcCtD
Carmustine—Myalgia—Epirubicin—liver cancer	0.000725	0.00137	CcSEcCtD
Carmustine—Agitation—Doxorubicin—liver cancer	0.000724	0.00137	CcSEcCtD
Carmustine—Anxiety—Epirubicin—liver cancer	0.000722	0.00136	CcSEcCtD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000717	0.00152	CbGpPWpGaD
Carmustine—Leukopenia—Doxorubicin—liver cancer	0.000705	0.00133	CcSEcCtD
Carmustine—Confusional state—Epirubicin—liver cancer	0.000701	0.00132	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—NR1H4—liver cancer	0.000699	0.00148	CbGpPWpGaD
Carmustine—Oedema—Epirubicin—liver cancer	0.000695	0.00131	CcSEcCtD
Carmustine—Infection—Epirubicin—liver cancer	0.00069	0.0013	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—GSTA3—liver cancer	0.000687	0.00146	CbGpPWpGaD
Carmustine—Convulsion—Doxorubicin—liver cancer	0.000683	0.00129	CcSEcCtD
Carmustine—Thrombocytopenia—Epirubicin—liver cancer	0.00068	0.00129	CcSEcCtD
Carmustine—Hypertension—Doxorubicin—liver cancer	0.00068	0.00128	CcSEcCtD
Carmustine—Tachycardia—Epirubicin—liver cancer	0.000678	0.00128	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—GSTA3—liver cancer	0.000677	0.00144	CbGpPWpGaD
Carmustine—Chest pain—Doxorubicin—liver cancer	0.000671	0.00127	CcSEcCtD
Carmustine—Myalgia—Doxorubicin—liver cancer	0.000671	0.00127	CcSEcCtD
Carmustine—Anxiety—Doxorubicin—liver cancer	0.000668	0.00126	CcSEcCtD
Carmustine—Anorexia—Epirubicin—liver cancer	0.000662	0.00125	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.000651	0.00138	CbGpPWpGaD
Carmustine—Hypotension—Epirubicin—liver cancer	0.000649	0.00123	CcSEcCtD
Carmustine—GSR—Metabolism—HPGDS—liver cancer	0.000649	0.00138	CbGpPWpGaD
Carmustine—Confusional state—Doxorubicin—liver cancer	0.000648	0.00122	CcSEcCtD
Carmustine—Oedema—Doxorubicin—liver cancer	0.000643	0.00121	CcSEcCtD
Carmustine—Infection—Doxorubicin—liver cancer	0.000639	0.00121	CcSEcCtD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000635	0.00135	CbGpPWpGaD
Carmustine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000633	0.0012	CcSEcCtD
Carmustine—Thrombocytopenia—Doxorubicin—liver cancer	0.00063	0.00119	CcSEcCtD
Carmustine—Insomnia—Epirubicin—liver cancer	0.000629	0.00119	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—GSTA4—liver cancer	0.000628	0.00134	CbGpPWpGaD
Carmustine—Tachycardia—Doxorubicin—liver cancer	0.000628	0.00119	CcSEcCtD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000627	0.00133	CbGpPWpGaD
Carmustine—Paraesthesia—Epirubicin—liver cancer	0.000624	0.00118	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—GSTA4—liver cancer	0.00062	0.00132	CbGpPWpGaD
Carmustine—Dyspnoea—Epirubicin—liver cancer	0.00062	0.00117	CcSEcCtD
Carmustine—Somnolence—Epirubicin—liver cancer	0.000618	0.00117	CcSEcCtD
Carmustine—Anorexia—Doxorubicin—liver cancer	0.000613	0.00116	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—GSTA2—liver cancer	0.000612	0.0013	CbGpPWpGaD
Carmustine—Decreased appetite—Epirubicin—liver cancer	0.000604	0.00114	CcSEcCtD
Carmustine—Hypotension—Doxorubicin—liver cancer	0.000601	0.00113	CcSEcCtD
Carmustine—Gastrointestinal disorder—Epirubicin—liver cancer	0.0006	0.00113	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GGT1—liver cancer	0.000597	0.00127	CbGpPWpGaD
Carmustine—Pain—Epirubicin—liver cancer	0.000594	0.00112	CcSEcCtD
Carmustine—Constipation—Epirubicin—liver cancer	0.000594	0.00112	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—GSTA1—liver cancer	0.000591	0.00126	CbGpPWpGaD
Carmustine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000586	0.00111	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—NAT2—liver cancer	0.000584	0.00124	CbGpPWpGaD
Carmustine—Insomnia—Doxorubicin—liver cancer	0.000582	0.0011	CcSEcCtD
Carmustine—GSR—Metabolism—PSMA4—liver cancer	0.000578	0.00123	CbGpPWpGaD
Carmustine—GSR—Metabolism—PSMD10—liver cancer	0.000578	0.00123	CbGpPWpGaD
Carmustine—Paraesthesia—Doxorubicin—liver cancer	0.000577	0.00109	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	0.000576	0.00122	CbGpPWpGaD
Carmustine—Dyspnoea—Doxorubicin—liver cancer	0.000573	0.00108	CcSEcCtD
Carmustine—Feeling abnormal—Epirubicin—liver cancer	0.000573	0.00108	CcSEcCtD
Carmustine—Somnolence—Doxorubicin—liver cancer	0.000572	0.00108	CcSEcCtD
Carmustine—Gastrointestinal pain—Epirubicin—liver cancer	0.000568	0.00107	CcSEcCtD
Carmustine—GSR—Metabolism—GOT2—liver cancer	0.000563	0.0012	CbGpPWpGaD
Carmustine—Decreased appetite—Doxorubicin—liver cancer	0.000559	0.00106	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—TP53—liver cancer	0.000558	0.00119	CbGpPWpGaD
Carmustine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000555	0.00105	CcSEcCtD
Carmustine—Pain—Doxorubicin—liver cancer	0.00055	0.00104	CcSEcCtD
Carmustine—Constipation—Doxorubicin—liver cancer	0.00055	0.00104	CcSEcCtD
Carmustine—Body temperature increased—Epirubicin—liver cancer	0.000549	0.00104	CcSEcCtD
Carmustine—Abdominal pain—Epirubicin—liver cancer	0.000549	0.00104	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GSTP1—liver cancer	0.000537	0.00114	CbGpPWpGaD
Carmustine—Feeling abnormal—Doxorubicin—liver cancer	0.00053	0.001	CcSEcCtD
Carmustine—GSR—Metabolism—CYP2E1—liver cancer	0.000529	0.00112	CbGpPWpGaD
Carmustine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000526	0.000993	CcSEcCtD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000515	0.00109	CbGpPWpGaD
Carmustine—Hypersensitivity—Epirubicin—liver cancer	0.000512	0.000967	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—IL6—liver cancer	0.000511	0.00109	CbGpPWpGaD
Carmustine—Body temperature increased—Doxorubicin—liver cancer	0.000508	0.00096	CcSEcCtD
Carmustine—Abdominal pain—Doxorubicin—liver cancer	0.000508	0.00096	CcSEcCtD
Carmustine—Asthenia—Epirubicin—liver cancer	0.000499	0.000942	CcSEcCtD
Carmustine—GSR—Metabolism—CYCS—liver cancer	0.000495	0.00105	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTM1—liver cancer	0.000493	0.00105	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	0.00049	0.00104	CbGpPWpGaD
Carmustine—GSR—Metabolism—GOT1—liver cancer	0.000486	0.00103	CbGpPWpGaD
Carmustine—GSR—Metabolism—GGT1—liver cancer	0.000486	0.00103	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000483	0.00103	CbGpPWpGaD
Carmustine—Diarrhoea—Epirubicin—liver cancer	0.000475	0.000898	CcSEcCtD
Carmustine—Hypersensitivity—Doxorubicin—liver cancer	0.000474	0.000895	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—HPGDS—liver cancer	0.000467	0.000992	CbGpPWpGaD
Carmustine—Asthenia—Doxorubicin—liver cancer	0.000461	0.000871	CcSEcCtD
Carmustine—Dizziness—Epirubicin—liver cancer	0.00046	0.000868	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000442	0.00094	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000442	0.00094	CbGpPWpGaD
Carmustine—Vomiting—Epirubicin—liver cancer	0.000442	0.000835	CcSEcCtD
Carmustine—Diarrhoea—Doxorubicin—liver cancer	0.00044	0.000831	CcSEcCtD
Carmustine—Rash—Epirubicin—liver cancer	0.000438	0.000828	CcSEcCtD
Carmustine—Dermatitis—Epirubicin—liver cancer	0.000438	0.000827	CcSEcCtD
Carmustine—GSR—Metabolism—GSTP1—liver cancer	0.000436	0.000927	CbGpPWpGaD
Carmustine—Headache—Epirubicin—liver cancer	0.000435	0.000822	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000433	0.00092	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000432	0.000918	CbGpPWpGaD
Carmustine—GSR—Metabolism—HMOX1—liver cancer	0.00043	0.000914	CbGpPWpGaD
Carmustine—Dizziness—Doxorubicin—liver cancer	0.000425	0.000803	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000421	0.000895	CbGpPWpGaD
Carmustine—Nausea—Epirubicin—liver cancer	0.000413	0.00078	CcSEcCtD
Carmustine—Vomiting—Doxorubicin—liver cancer	0.000409	0.000772	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000408	0.000868	CbGpPWpGaD
Carmustine—Rash—Doxorubicin—liver cancer	0.000405	0.000766	CcSEcCtD
Carmustine—Dermatitis—Doxorubicin—liver cancer	0.000405	0.000765	CcSEcCtD
Carmustine—Headache—Doxorubicin—liver cancer	0.000403	0.000761	CcSEcCtD
Carmustine—GSR—Metabolism—GSTM1—liver cancer	0.000401	0.000852	CbGpPWpGaD
Carmustine—Nausea—Doxorubicin—liver cancer	0.000382	0.000721	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP2E1—liver cancer	0.000381	0.000809	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP1A1—liver cancer	0.00038	0.000808	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	0.000375	0.000798	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000368	0.000782	CbGpPWpGaD
Carmustine—GSR—Metabolism—MTHFR—liver cancer	0.000354	0.000753	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GGT1—liver cancer	0.000349	0.000743	CbGpPWpGaD
Carmustine—GSR—Metabolism—PPARA—liver cancer	0.000348	0.000739	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000339	0.000719	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000338	0.000718	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000315	0.00067	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000315	0.00067	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTP1—liver cancer	0.000314	0.000667	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000313	0.000665	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	0.00031	0.000658	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CG—liver cancer	0.000298	0.000633	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTM1—liver cancer	0.000288	0.000613	CbGpPWpGaD
Carmustine—GSR—Metabolism—PPARG—liver cancer	0.000287	0.00061	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	0.000284	0.000605	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000278	0.000591	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP1A1—liver cancer	0.000273	0.000581	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	0.00027	0.000573	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000268	0.00057	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000266	0.000565	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CD—liver cancer	0.000262	0.000556	CbGpPWpGaD
Carmustine—GSR—Metabolism—ALB—liver cancer	0.000258	0.000549	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CB—liver cancer	0.000228	0.000485	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000205	0.000436	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—UGDH—liver cancer	0.000205	0.000435	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—EPT1—liver cancer	0.000192	0.000409	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TAT—liver cancer	0.000182	0.000387	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000179	0.000381	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CA—liver cancer	0.000139	0.000295	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000134	0.000285	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CPT1B—liver cancer	0.000124	0.000263	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GLUL—liver cancer	0.000124	0.000263	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NR1H4—liver cancer	0.000119	0.000254	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA3—liver cancer	0.000117	0.00025	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKT1—liver cancer	0.000114	0.000241	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA4—liver cancer	0.000107	0.000228	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000105	0.000223	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA2—liver cancer	0.000105	0.000223	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTA1—liver cancer	0.000101	0.000215	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NAT2—liver cancer	9.99e-05	0.000212	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	9.6e-05	0.000204	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALDOB—liver cancer	9.58e-05	0.000204	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CRABP1—liver cancer	9.14e-05	0.000194	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.23e-05	0.000175	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HPGDS—liver cancer	7.98e-05	0.00017	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.94e-05	0.000169	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.23e-05	0.000154	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.14e-05	0.000152	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PSMD10—liver cancer	7.12e-05	0.000151	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PSMA4—liver cancer	7.12e-05	0.000151	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GOT2—liver cancer	6.92e-05	0.000147	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP2E1—liver cancer	6.51e-05	0.000138	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.3e-05	0.000134	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYCS—liver cancer	6.09e-05	0.000129	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GOT1—liver cancer	5.98e-05	0.000127	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GGT1—liver cancer	5.98e-05	0.000127	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTP1—liver cancer	5.37e-05	0.000114	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HMOX1—liver cancer	5.29e-05	0.000113	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTM1—liver cancer	4.93e-05	0.000105	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP1A1—liver cancer	4.68e-05	9.94e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MTHFR—liver cancer	4.36e-05	9.27e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPARA—liver cancer	4.28e-05	9.09e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.84e-05	8.17e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CG—liver cancer	3.66e-05	7.78e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPARG—liver cancer	3.54e-05	7.51e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CD—liver cancer	3.22e-05	6.84e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALB—liver cancer	3.18e-05	6.76e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CB—liver cancer	2.81e-05	5.97e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CA—liver cancer	1.71e-05	3.64e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—liver cancer	1.4e-05	2.97e-05	CbGpPWpGaD
